Skip to content

Thymosin alpha-1 studies: 615 papers with results

Page 2 of 13

  1. Thymosin-ɑ1 for people with chronic hepatitis B.

    Naing C · The Cochrane database of systematic reviews · 2026

    Systematic review · 7 results

  2. The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials.

    Liu F · BMC infectious diseases · 2016

    Systematic review · 13 results

  3. Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis.

    Zhang YY · Virology journal · 2009

    Systematic review · 3 results

  4. Ulinastatin and/or thymosin α1 for severe sepsis: A systematic review and meta-analysis.

    Feng Z · The journal of trauma and acute care surgery · 2016

    Systematic review · 4 results

  5. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis.

    Yang YF · Antiviral research · 2008

    Systematic review · 6 results

  6. Interventions for treating traumatised permanent front teeth: avulsed (knocked out) and replanted.

    Day PF · The Cochrane database of systematic reviews · 2019

    Systematic review · 2 results

  7. Thymic peptides for treatment of cancer patients.

    Wolf E · The Cochrane database of systematic reviews · 2011

    Systematic review · 2 results

  8. Interventions for treating traumatised permanent front teeth: avulsed (knocked out) and replanted.

    Day P · The Cochrane database of systematic reviews · 2010

    Systematic review · 1 result

  9. [Treatment with interferon and thymosin alpha-1 versus interferon monotherapy for HBeAg positive chronic hepatitis B: a meta-analysis].

    Mao HY · Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2011

    Systematic review · 9 results

  10. The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis.

    Peng D · BMC gastroenterology · 2020

    Systematic review · 8 results

  11. [Evaluation of efficacy of thymosin alpha1 in the treatment of sepsis: a systematic review].

    Yu Y · Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue · 2009

    Systematic review · 5 results

  12. The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression.

    Soeroto AY · Inflammopharmacology · 2023

    Systematic review · 4 results

  13. Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis.

    Tian Y · Frontiers in immunology · 2025

    Systematic review · 11 results

  14. Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.

    Cao A · Journal of the College of Physicians and Surgeons--Pakistan : JCPSP · 2024

    Systematic review · 8 results

  15. Efficacy and safety of thymosin α1 combined with chemotherapy for gastric cancer: a systematic review and meta-analysis of randomized controlled trials.

    Wang Z · Frontiers in immunology · 2026

    Systematic review · 19 results

  16. Efficacy of Thymosin α1 in Management of Radiation Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiotherapy: A Phase 2 Clinical Trial (GASTO-1043).

    Liu F · International journal of radiation oncology, biology, physics · 2022

    Non-randomized trial · 6 results

  17. Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study.

    Carraro G · Vaccine · 2012

    Non-randomized trial · 7 results

  18. Clinical effect of Xuebijing combined with thymosinα1 on patients with severe pneumonia complicated with sepsis and its effect on serum inflammatory factors.

    Chen Y · Cellular and molecular biology (Noisy-le-Grand, France) · 2022

    Non-randomized trial · 11 results

  19. Treatment with thymosin alpha-1 increases fertilizing capacity of sperm of infertile men: a multicenter trial.

    Naz RK · Archives of andrology · 1995

    Non-randomized trial · 3 results

  20. [Combination therapy of thymosin alpha1 and high dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura].

    Wang L · Zhonghua nei ke za zhi · 2007

    Non-randomized trial · 14 results

  21. Effect of thymalfasin on myeloid-derived suppressor cells in patients with non-small cell lung cancer.

    Shi F · American journal of translational research · 2024

    Non-randomized trial · 2 results

  22. Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.

    Saruc M · Journal of pharmaceutical sciences · 2003

    Non-randomized trial · 6 results

  23. [Effect of transcatheter arterial chemoembolization combined with thymosin alpha 1 on the autophagy of immune cells from advanced hepatocellular carcinoma].

    Fang SJ · Zhonghua yi xue za zhi · 2017

    Non-randomized trial · 9 results

  24. [Effect of thymosin alpha 1 on cellular immune function in elderly patients with malignant tumor].

    Yang YM · Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2003

    Non-randomized trial · 4 results

  25. Immunological modifications during treatment with thymosin alpha1 plus antiviral therapy in chronic hepatitis C.

    Grandini E · Annals of the New York Academy of Sciences · 2010

    Non-randomized trial · 2 results

  26. [Primary assessment of treatment effect of thymosin alpha1 on chemotherapy-induced neurotoxicity].

    An TT · Ai zheng = Aizheng = Chinese journal of cancer · 2004

    Non-randomized trial · 1 result

  27. Role of thymosin α1 in restoring immune response in immunological nonresponders living with HIV.

    Chen C · BMC infectious diseases · 2024

    Non-randomized trial · 11 results

  28. [B domain mutations in the polymerase gene of hepatitis B virus during combination therapy with thymosin alpha1 and famciclovir in Chinese asymptomatic HBV carriers].

    Hou J · Zhonghua yi xue za zhi · 2000

    Non-randomized trial · 3 results

  29. In vivo immune restoration in advanced cancer patients after administration of thymosin fraction 5 or thymosin alpha 1.

    Dillman RO · Journal of biological response modifiers · 1983

    Non-randomized trial · 7 results

  30. Thymosin-alpha1 increases intrahepatic NKT cells and CTLs in patients with chronic hepatitis B.

    Sugahara S · Hepatology research : the official journal of the Japan Society of Hepatology · 2002

    Non-randomized trial · 11 results

  31. IRX-2 and thymosin alpha1 (Zadaxin) increase T lymphocytes in T lymphocytopenic mice and humans.

    Hadden JW · Annals of the New York Academy of Sciences · 2007

    Non-randomized trial · 4 results

  32. Thymosin alpha1 to harness immunity to pathogens after haploidentical hematopoietic transplantation.

    Perruccio K · Annals of the New York Academy of Sciences · 2010

    Non-randomized trial · 8 results

  33. Indications for an antidepressive effect of thymosin alpha-1 in a small open-label proof of concept study in common variable immune deficiency patients with depression.

    Aynekulu Mersha DG · Brain, behavior, & immunity - health · 2025

    Non-randomized trial · 6 results

  34. Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase.

    Lau GK · Journal of viral hepatitis · 2002

    Non-randomized trial · 4 results

  35. Development and application of a high-throughput liquid chromatography-tandem mass spectrometric method for the simultaneous determination of thymosin α1 and its recombinant human form in plasma and urine.

    Wang T · Journal of pharmaceutical and biomedical analysis · 2019

    Non-randomized trial · 3 results

  36. Effect analysis of entecavir on serum hyaluronic acid, laminin and IV collagen in the treatment of hepatitis B E-antigen-positive chronic hepatitis B.

    Qian J · African health sciences · 2024

    Non-randomized trial · 6 results

  37. The effect of thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study.

    Sun Q · International immunopharmacology · 2021

    Observational study · 6 results

  38. Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanisms.

    Wang Z · Pneumonia (Nathan Qld.) · 2023

    Observational study · 5 results

  39. Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study.

    Wu M · International immunopharmacology · 2020

    Observational study · 7 results

  40. [Thymosin alpha 1 for the adjuvant treatment of coronavirus disease 2019: a retrospective cohort study].

    Wang T · Zhonghua wei zhong bing ji jiu yi xue · 2022

    Observational study · 8 results

  41. Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study.

    Liu J · Frontiers in immunology · 2021

    Observational study · 11 results

  42. The efficacy and safety of thymosin alpha-1 combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a retrospective study.

    Yao S · Scientific reports · 2025

    Observational study · 6 results

  43. Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after R0 resection: a propensity score-matched analysis.

    Guo CL · Chinese medical journal · 2021

    Observational study · 6 results

  44. Thymosin alpha-1 therapy improves postoperative survival after curative resection for solitary hepatitis B virus-related hepatocellular carcinoma: A propensity score matching analysis.

    Linye H · Medicine · 2021

    Observational study · 6 results

  45. Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients.

    Wang Z · Frontiers in immunology · 2021

    Observational study · 5 results

  46. Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection.

    He C · Medicine · 2017

    Observational study · 4 results

  47. Unveiling lymphocyte dynamics: Navigating postoperative immune landscapes in gastric cancer patients undergoing laparoscopic D2 gastrectomy.

    Gao C · International journal of immunopathology and pharmacology · 2025

    Observational study · 3 results

  48. Thymosin α1 Combined With 2HRZE/4HR Regimen as a Potential Treatment of Pulmonary Tuberculosis: An Analysis of Immune Function, Pulmonary Function and Inflammatory Response.

    Wu G · British journal of hospital medicine (London, England : 2005) · 2025

    Observational study · 14 results

  49. Gender-associated difference following COVID-19 virus infection: Implications for thymosin alpha-1 therapy.

    Li X · International immunopharmacology · 2021

    Observational study · 4 results

  50. Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells.

    Liu Y · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020

    Observational study · 7 results

How PepBank reports evidence